Showing results (1001-1010 of 1,396) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|July 27, 2023
Clinical Implication of HER2 Aberration in Patients With Metastatic Cancer Using Next-Generation Sequencing: A Pan-Tumor AnalysisJaeyun Jung, Seung Tae Kim, Jihoon Ko, et al.
JCO Precision Oncology|August 10, 2023
The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With CholangiocarcinomaLeontios Pappas, Islam Baiev, Stephanie Reyes, et al.
JCO Precision Oncology|March 18, 2026
Genomic Features and Response to Poly(ADP-ribose) Polymerase Inhibition in Metastatic Castration-Resistant Prostate CancerJeffery C W Chang, Subhiksha Nandakumar, Konrad H Stopsack, et al.
JCO Precision Oncology|April 18, 2024
Tumor Size Is Not Everything: Advancing Radiomics as a Precision Medicine Biomarker in Oncology Drug Development and Clinical Care. A Report of a Multidisciplinary Workshop Coordinated by the RECIST Working GroupErica C Nakajima, Amber Simpson, Jan Bogaerts, et al.
JCO Precision Oncology|April 11, 2024
Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2Jun Gong, Alain C Mita, Zihan Wei, et al.
JCO Precision Oncology|May 6, 2024
Lethal Capecitabine Toxicity in Patients With Complete Dihydropyrimidine Dehydrogenase Deficiency Due to Ultra-Rare DPYD VariantsAndré B P van Kuilenburg, Marjolein C H Pleunis-van Empel, Rick B Brouwer, et al.
JCO Precision Oncology|May 9, 2024
Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of Pancreatic Carcinomas: In Search of Therapeutic TargetsErik B Faber, Harris B Krause, Khalid Amin, et al.
JCO Precision Oncology|May 6, 2024
Spontaneous and Treatment-Related Changes of Serum Calcitonin in Medullary Thyroid Cancer: Long-Term Experience in a Patient With Multiple Endocrine Neoplasia Type 2BZsuzsanna Réti, Ádám Gy Tabák, Miklós Garami, et al.
JCO Precision Oncology|April 25, 2024
Melanocortin-1 Receptor Expression as a Marker of Progression in MelanomaDavid G Su, Dijana Djureinovic, David Schoenfeld, et al.
JCO Precision Oncology|May 1, 2024
Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast CancerJacqueline A Shaw, Karen Page, Evie Wren, et al.
Pageof 140